BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30

• Press Releases

  Ridge Biotechnologies Expands Investor Base as Demand Accelerates for AI-Designed Bioconjugate Therapeutics

  September 9, 2026

   · 

  5 min read
• Press Releases

  Crossbow Therapeutics Doses First Patient in Phase 1 Trial of CBX-663 for Treatment of Multiple Hematologic and Solid Malignancies

  September 9, 2026

   · 

  3 min read
• Press Releases

  GeneDx and Beren Therapeutics Launch NPC GenomeComplete to Improve Diagnosis of Niemann-Pick Disease Type C

  September 9, 2026

   · 

  6 min read
• Press Releases

  Shionogi to Showcase Advancements Across its Infectious Disease Portfolio at IDWeek 2026

  September 9, 2026

   · 

  7 min read
• Press Releases

  Xeris Hosts Webinar Detailing Its Comprehensive Development Program for XP-8121, an Investigational, Once-Weekly Subcutaneous Levothyroxine for Hypothyroidism

  September 9, 2026

   · 

  10 min read
• Press Releases

  Encoded Therapeutics Raises $275 Million in Series F Financing to Advance ETX101 Through Pivotal Development and Accelerate its Precision Genetic Medicines Neurology Pipeline

  September 9, 2026

   · 

  3 min read
• Press Releases

  Silo Pharma to Highlight Patented Nose-to-Brain Drug Delivery Technology for PTSD at 2026 Nasal Innovation Forum

  September 9, 2026

   · 

  3 min read
• Press Releases

  AIM ImmunoTech Highlights Scientific Rationale, Supportive Data and Continued Advancement of Ampligen® in Pancreatic Cancer in New CEO Corner Video

  September 9, 2026

   · 

  7 min read
• Press Releases

  Editas Medicine Reports Inducement Grants to New Chief Medical Officer

  September 9, 2026

   · 

  1 min read
• Press Releases

  ImPact Biotech Announces Completion of Treatment in Phase 3 ENLIGHTED Trial of Padeliporfin VTP in LG-UTUC and Positive Regulatory Updates

  September 9, 2026

   · 

  5 min read